VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Clinical trial NCT00516282 · TERMINATED

Trial details

NCT number: NCT00516282
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2007-08-01
Primary completion: 2009-10-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.